相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis
Mitzy Kennis et al.
MOLECULAR PSYCHIATRY (2020)
Vascular safety of erenumab for migraine prevention
David Kudrow et al.
NEUROLOGY (2020)
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
Stewart J. Tepper et al.
CEPHALALGIA (2020)
One-year sustained efficacy of erenumab in episodic migraine Results of the STRIVE study
Peter J. Goadsby et al.
NEUROLOGY (2020)
Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future
Muaed Alomar et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2020)
Erenumab: A First-in-Class Monoclonal Antibody for Migraine Prevention
Scott G. Garland et al.
ANNALS OF PHARMACOTHERAPY (2019)
Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety
Simona Lattanzi et al.
DRUGS (2019)
Psychosis as an adverse effect of monoclonal antibody immunotherapy
Norah Essali et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Messoud Ashina et al.
CEPHALALGIA (2019)
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions
Messoud Ashina et al.
CEPHALALGIA (2019)
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults
Fumihiko Sakai et al.
HEADACHE (2019)
Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study
Lotte A. Minnema et al.
DRUG SAFETY (2019)
Erenumab safety and efficacy in migraine A systematic review and meta-analysis of randomized clinical trials
Changyu Zhu et al.
MEDICINE (2019)
Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled Receptor
Chadwick Terence King et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2019)
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W. Dodick et al.
CEPHALALGIA (2018)
Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors
Maurizio Sessa et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects
Zizheng Kee et al.
FRONTIERS IN PHYSIOLOGY (2018)
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Uwe Reuter et al.
LANCET (2018)
Pituitary gland in Bipolar Disorder and Major Depression: Evidence from structural MRI studies
G. Delvecchio et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis
Min Hou et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting
Annamaria Mascolo et al.
PHARMACOLOGICAL RESEARCH (2017)
Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
Maurizio Sessa et al.
FRONTIERS IN PHARMACOLOGY (2017)
Calcitonin gene-related peptide (CGRP): A novel target for Alzheimer's disease
Yogendra Singh et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
OpenFDA: an innovative platform providing access to a wealth of FDA's publicly available data
Taha A. Kass-Hout et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2016)
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs
Maurizio Sessa et al.
Expert Opinion On Drug Safety (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Distinct calcitonin gene- related peptide expression pattern in primary afferents contribute to different neuropathic symptoms following chronic constriction or crush injuries to the rat sciatic nerve
Yu Zou et al.
MOLECULAR PAIN (2016)
A case of figurate urticaria by etanercept
Maurizio Sessa et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2016)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
Suspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillance
Maurizio Sessa et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Migraine and body mass index categories: a systematic review and meta-analysis of observational studies
Raffaele Ornello et al.
JOURNAL OF HEADACHE AND PAIN (2015)
Calcitonin Gene-Related Peptide Reduces Taste-Evoked ATP Secretion from Mouse Taste Buds
Anthony Y. Huang et al.
JOURNAL OF NEUROSCIENCE (2015)
Tinnitus and Headache
Berthold Langguth et al.
BIOMED RESEARCH INTERNATIONAL (2015)
New insights into pathophysiology of vestibular migraine
Juan M. Espinosa-Sanchez et al.
FRONTIERS IN NEUROLOGY (2015)
Cephalalgia Alopecia or Nummular Headache With Trophic Changes? A New Case With Prolonged Follow-Up
Pablo Irimia et al.
HEADACHE (2013)
Data Mining of the Public Version of the FDA Adverse Event Reporting System
Toshiyuki Sakaeda et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Gastroesophageal reflux disease: Update on inflammation and symptom perception
Annamaria Altomare et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Migraine prevalence by age and sex in the United States: A life-span study
T. W. Victor et al.
CEPHALALGIA (2010)
Migraine-Associated Vertigo: Diagnosis and Treatment
Yoon-Hee Cha
SEMINARS IN NEUROLOGY (2010)
Effects of NSAIDs on the Inner Ear: Possible Involvement in Cochlear Protection
Tomofumi Hoshino et al.
PHARMACEUTICALS (2010)
Brain Regulation of Appetite and Satiety
Rexford S. Ahima et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine
Stewart J. Tepper et al.
HEADACHE (2008)
The prevalence of acne in adults 20 years and older
Christin N. Collier et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Neurovascular Pains: Implications of Migraine for the Oral and Maxillofacial Surgeon
Donald R. Nixdorf et al.
Oral and Maxillofacial Surgery Clinics of North America (2008)
Calcitonin gene-related peptide relates to cough sensitivity in children with chronic cough
A. B. Chang et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Age-dependent prevalence and clinical features of migraine
Marcelo E. Bigal et al.
NEUROLOGY (2006)
Ultrastructural evaluation of calcitonin gene-related peptide immunoreactivity in the human cochlea and vestibular endorgans
WJ Kong et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
分享论文
